Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R P Alexander

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The International Journal of Psycho-Analysis|January 11, 2000
On Feldman's 'Some views on the manifestation of the death instinct in clinical work'R P Alexander
Journal of the National Medical Association|October 5, 2010
The Legal Aspects Of Medical EconomicsR P Alexander
The International Journal of Psycho-Analysis|January 1, 1988
Autistic objectsR P Alexander
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimizationC Li, N Chauret, L A Trimble, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The International Journal of Psycho-Analysis|January 11, 2000
On Feldman's 'Some views on the manifestation of the death instinct in clinical work'R P Alexander
Journal of the National Medical Association|October 5, 2010
The Legal Aspects Of Medical EconomicsR P Alexander
The International Journal of Psycho-Analysis|January 1, 1988
Autistic objectsR P Alexander
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 22, 2001
Investigation of the in vitro metabolism profile of a phosphodiesterase-IV inhibitor, CDP-840: leading to structural optimizationC Li, N Chauret, L A Trimble, et al.
Bioorganic & Medicinal Chemistry Letters|May 29, 2002
CDP840. A prototype of a novel class of orally active anti-inflammatory phosphodiesterase 4 inhibitorsR P Alexander, G J Warrellow, M A W Eaton, et al.
Pageof 1